Posts tagged Axis Securities
| Pitti Engineering: Strategic operation will support improving ROE and ROCE to 25.8% and 26.7%. Buy for target price of Rs 915 (40% upside) | |
| Company: | Pitti Engineering |
| Brokerage: | Axis Securities |
| Date of report: | December 1, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 40% |
| Summary: | We initiate coverage on Pitti Engineering Ltd. (PEL) with a BUY recommendation. Our recommendation is supported by a) The company’s increasing capacity b) Its increasing share of value-added products, and c) Its expanding global footprints |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Pitti Engineering |
| Review of 9 Specialty Chemical Stocks And 3 Stock Recommendations by Axis Securities | |
| Company: | Speciality Chemicals stocks |
| Brokerage: | Axis Securities |
| Date of report: | November 26, 2023 |
| Type of Report: | Sector Report |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | Structural story of Indian Chemical industry remains strong with strategic portfolio composition to gain export market share, and strong domestic demand we expect revenue growth to gain momentum from FY25 onward. Given the changing landscape and growing reliance on India by international customers, we expect rapid growth in this sector over the coming period as conditions stabilize |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Speciality Chemicals |
| Axis Top Picks basket has outperformed the benchmark by a significant margin due to thematic approach to Top Picks selection | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | January 15, 2023 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 54% |
| Summary: | Axis Top Picks basket outperformed the benchmark by a significant margin as it delivered an impressive return of 11% in 2022 as against 4.3% posted by Nifty 50 during the year |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Top 6 Festival Unlock Stocks By Axis Securities | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | September 25, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 19% |
| Summary: | Festival Unlock Picks September 2021 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| NIFTY target raised to 17400 + Top 16 Small Cap, Mid Cap and Large Cap Stocks To Buy | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | July 1, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 33% |
| Summary: | Raise December NIFTY target to 17400 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio, NIFTY, Top Picks |
| Navin Fluorine Has Strong Growth Chemistry: Axis Securities | |
| Company: | Navin Fluorine |
| Brokerage: | Axis Securities |
| Date of report: | June 17, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Strong Growth Chemistry |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Navin Fluorine |
| Covid 2.0: Investment Ideas | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | April 23, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 39% |
| Summary: | Reduce NIFTY50 target to 16100 but remain cautiously optimistic |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Axis Top Picks for April 2021 | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | April 1, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | New Fiscal; New Hope! |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |
| Gland Pharma Initiating Coverage Research Report By Axis Securities | |
| Company: | Gland Pharma Ltd |
| Brokerage: | Axis Securities |
| Date of report: | March 9, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 15% |
| Summary: | Well-positioned to Capitalise Fast-growing Generic Injectibles Market |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Gland Pharma Ltd |
| NIFTY Target Upgraded To 17,200 + Best 15 Stocks To Buy Now: Axis Securities Report | |
| Company: | Model Portfolio |
| Brokerage: | Axis Securities |
| Date of report: | March 2, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 36% |
| Summary: | Structural trends intact; Upgrade Nifty Target to 17,200 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |